Publications by authors named "J R Hedberg"

Purpose: Oligometastatic gastroesophageal cancer is a clinical entity with no standard treatment recommendation. Treatment with curative intent has recently emerged as an option for selected patients in contrast to the traditional palliative treatment strategy. This prospective study aimed to assess the safety and efficacy of combined systemic and local treatment with curative intent for patients with oligometastatic gastroesophageal cancer.

View Article and Find Full Text PDF

Background: There are differences in oesophageal cancer care across Sweden. According to national guidelines, all patients should be offered equal care, planned and administrated by regional multidisciplinary team meetings. The aim of the study was to investigate differences between regional multidisciplinary team meetings in Sweden regarding clinical staging and treatment recommendations for oesophageal cancer patients.

View Article and Find Full Text PDF

Introduction: Traces of hexavalent chromium, Cr(VI), are a major concern for skin contact with Cr-tanned leather. Current extraction methods (ISO 17075-1:2017) for Cr(VI) testing do not necessarily reflect the true potential of surface-formed Cr(VI), as extracted concentrations are dependent on previous storage and atmospheric conditions.

Objectives: To test whether a spiking method protocol can distinguish leathers with high and low risks of releasing Cr(VI).

View Article and Find Full Text PDF

Background: Centralized surgery care improves curative resection outcomes in rare malignancies. Less is known about the secondary effects of such centralization on all patients, including patients receiving palliative treatment or no tumor treatment. This population-based cohort study aimed to evaluate the effects of centralization on survival and treatment decision in all patients with gastric cancer in Sweden between 2006 and 2016.

View Article and Find Full Text PDF

High-grade gliomas (HGGs) and glioblastomas (GBMs) are the most aggressive and lethal brain tumors. The current standard of care (SOC) includes gross safe surgical resection followed by chemoradiotherapy. The main chemotherapeutic agents are the DNA-alkylating agent temozolomide (TMZ) and adjuvants.

View Article and Find Full Text PDF